Increased Prevalence of Flammer Syndrome in Patients with Retinitis Pigmentosa

Klinische Monatsblatter fur Augenheilkunde

Volumn 233, Issue 4, 2016, Pages 448-452

  Konieczka, Katarzyna ^a   Koch, S ^a   Schoetzau, A ^a   Todorova, M G ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

endothelin; Flammer syndrome; ocular blood flow; Retinitis pigmentosa; vascular dysregulation

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BODY MASS; COLD; CONTROLLED STUDY; EMOTIONAL STRESS; FLAMMER SYNDROME; GENE EXPRESSION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MIGRAINE; PREVALENCE; RETINITIS PIGMENTOSA; SEX DIFFERENCE; SYNDROME; VASCULAR DISEASE; ADULT; AGED; CAUSALITY; COMORBIDITY; FEMALE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RISK FACTOR; SENSATION DISORDERS; SWITZERLAND;

ADULT; AGED; CAUSALITY; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; RETINITIS PIGMENTOSA; RISK FACTORS; SENSATION DISORDERS; SWITZERLAND; SYNDROME;

EID: 84966694648     PISSN: 00232165     EISSN: 14393999     Source Type: Journal    
DOI: 10.1055/s-0041-111802     Document Type: Article

References (57)

1. Kajiwara K., Berson E. L., Dryja T. P. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science: 1994; 264 1604 1608
2. Mansergh F. C., Millington-Ward S., Kennan A. et al. Retinitis pigmentosa and progressive sensorineural hearing loss caused by a C12258A mutation in the mitochondrial MTTS2 gene. Am J Hum Genet: 1999; 64 971 985
3. Ferrari S., Di Iorio E., Barbaro V. et al. Retinitis pigmentosa: genes and disease mechanisms. Curr Genomics: 2011; 12 238 249
4. Grunwald J. E., Maguire A. M., Dupont J. Retinal hemodynamics in retinitis pigmentosa. Am J Ophthalmol: 1996; 122 502 508
5. Falsini B., Anselmi G. M., Marangoni D. et al. Subfoveal choroidal blood flow and central retinal function in retinitis pigmentosa. Invest Ophthalmol Vis Sci: 2011; 52 1064 1069
6. Cellini M., Strobbe E., Gizzi C. et al. ET-1 plasma levels and ocular blood flow in retinitis pigmentosa. Can J Physiol Pharmacol: 2010; 88 630 635
7. Polak K., Petternel V., Luksch A. et al. Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects. Invest Ophthalmol Vis Sci: 2001; 42 2949 2956
8. Cellini M., Santiago L., Versura P. et al. Plasma levels of endothelin-1 in retinitis pigmentosa. Ophthalmologica: 2002; 216 265 268
9. Vingolo E. M., Lupo S., Grenga P. L. et al. Endothelin-1 plasma concentrations in patients with retinitis pigmentosa. Regul Pept: 2010; 160 64 67
10. Finzi A., Cellini M., Strobbe E. et al. ET-1 plasma levels, choroidal thickness and multifocal electroretinogram in retinitis pigmentosa. Life Sci: 2014; 118 386 390
11. Todorova M. G., Josifova T., Konieczka K. Endothelin-1 Plasma Levels in Patients with both Retinitis Pigmentosa and Flammer Syndrome. Klin Monbl Augenheilkd: 2015; 232 514 518
12. Ohguro H., Mashima Y., Nakazawa M. Low levels of plasma endothelin-1 in patients with retinitis pigmentosa. Clin Ophthalmol: 2010; 4 569 573
13. Strobbe E., Cellini M., Fresina M. et al. ET-1 Plasma Levels, Aqueous Flare, and Choroidal Thickness in Patients with Retinitis Pigmentosa. J Ophthalmol: 2015; 2015 292615
14. Nakazawa M., Ohguro H., Takeuchi K. et al. Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial. Ophthalmologica: 2011; 225 120 126
15. Liang S. Y., Lee L. R. Retinitis pigmentosa associated with hypomagnesaemia. Clin Experiment Ophthalmol: 2010; 38 645 647
16. Meyer P., Lang M. G., Flammer J. et al. Effects of calcium channel blockers on the response to endothelin-1, bradykinin and sodium nitroprusside in porcine ciliary arteries. Exp Eye Res: 1995; 60 505 510
17. Dettmann E. S., Luscher T. F., Flammer J. et al. Modulation of endothelin-1-induced contractions by magnesium/calcium in porcine ciliary arteries. Graefes Arch Clin Exp Ophthalmol: 1998; 236 47 51
18. Konieczka K., Flammer A. J., Todorova M. et al. Retinitis pigmentosa and ocular blood flow. EPMA J: 2012; 3 17
19. Sorrentino F. S., Bonifazzi C., Perri P. The Role of the Endothelin System in the Vascular Dysregulation Involved in Retinitis Pigmentosa. J Ophthalmol: 2015; 2015 405234
20. Konieczka K., Ritch R., Traverso C. E. et al. Flammer syndrome. EPMA J: 2014; 5 11
21. Flammer J., Konieczka K., Flammer A. J. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J: 2013; 4 14
22. Flammer J., Konieczka K., Bruno R. M. et al. The eye and the heart. Eur Heart J: 2013; 34 1270 1278
23. Saner H., Wurbel H., Mahler F. et al. Microvasculatory evaluation of vasospastic syndromes. Adv Exp Med Biol: 1987; 220 215 218
24. Guthauser U., Flammer J., Mahler F. The relationship between digital and ocular vasospasm. Graefes Arch Clin Exp Ophthalmol: 1988; 226 224 226
25. Mozaffarieh M., Fontana Gasio P., Schotzau A. et al. Thermal discomfort with cold extremities in relation to age, gender, and body mass index in a random sample of a Swiss urban population. Popul Health Metr: 2010; 8 17
26. Kavroulaki D., Gugleta K., Kochkorov A. et al. Relation of body mass index and blood pressure to subjective and objective acral temperature. Klin Monbl Augenheilkd: 2009; 226 328 331
27. Gasser P., Stumpfig D., Schotzau A. et al. Body mass index in glaucoma. J Glaucoma: 1999; 8 8 11
28. Flammer J. Glaucoma. 3rd edn. Bern Hogrefe & Huber: 2006
29. Emre M., Orgul S., Gugleta K. et al. Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation. Br J Ophthalmol: 2004; 88 662 666
30. Kochkorov A., Gugleta K., Zawinka C. et al. Short-term retinal vessel diameter variability in relation to the history of cold extremities. Invest Ophthalmol Vis Sci: 2006; 47 4026 4033
31. Oettli A., Gugleta K., Kochkorov A. et al. Rigidity of retinal vessel in untreated eyes of normal tension primary open-angle glaucoma patients. J Glaucoma: 2011; 20 303 306
32. Gugleta K., Zawinka C., Rickenbacher I. et al. Analysis of retinal vasodilation after flicker light stimulation in relation to vasospastic propensity. Invest Ophthalmol Vis Sci: 2006; 47 4034 4041
33. Gugleta K., Kochkorov A., Waldmann N. et al. Dynamics of retinal vessel response to flicker light in glaucoma patients and ocular hypertensives. Graefes Arch Clin Exp Ophthalmol: 2012; 250 589 594
34. Fang L., Baertschi M., Mozaffarieh M. The effect of flammer-syndrome on retinal venous pressure. BMC Ophthalmol: 2014; 14 121
35. Flammer J., Orgul S., Costa V. P. et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res: 2002; 21 359 393
36. Konieczka K., Frankl S., Todorova M. G. et al. Unstable oxygen supply and glaucoma. Klin Monbl Augenheilkd: 2014; 231 121 126
37. Yeghiazaryan K., Flammer J., Orgul S. et al. Vasospastic individuals demonstrate significant similarity to glaucoma patients as revealed by gene expression profiling in circulating leukocytes. Mol Vis: 2009; 15 2339 2348
38. Konieczka K., Choi H. J., Koch S. et al. Frequency of symptoms and signs of primary vascular dysregulation in Swiss and Korean populations. Klin Monbl Augenheilkd: 2014; 231 344 347
39. Team R. DC. R: A Language and Environment for Statistical Computing. Vienna, Austria R Foundation for Statistical Computing: 2012
40. Heckenlively J. R., Yoser S. L., Friedman L. H. et al. Clinical findings and common symptoms in retinitis pigmentosa. Am J Ophthalmol: 1988; 105 504 511
41. Iwasaki S., Maruyama Y., Hotta Y. et al. Survey in to the prevalence of hearing loss in patients diagnosed with retinitis pigmentosa. Int Ophthalmol: 2004; 25 277 282
42. Mozaffarieh M., Schoetzau A., Sauter M. et al. Comet assay analysis of single-stranded DNA breaks in circulating leukocytes of glaucoma patients. Mol Vis: 2008; 14 1584 1588
43. Komeima K., Rogers B. S., Lu L. et al. Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc Natl Acad Sci U S A: 2006; 103 11300 11305
44. Martinez-Fernandez de la Camara C., Salom D., Sequedo M. D. et al. Altered antioxidant-oxidant status in the aqueous humor and peripheral blood of patients with retinitis pigmentosa. PLoS One: 2013; 8 e74223
45. Gaspar A. Z., Gasser P., Flammer J. The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Ophthalmologica: 1995; 209 11 13
46. Strenn K., Matulla B., Wolzt M. et al. Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans. Clin Pharmacol Ther: 1998; 63 54 63
47. Nyby M. D., Hori M. T., Ormsby B. et al. Eicosapentaenoic acid inhibits Ca2+ mobilization and PKC activity in vascular smooth muscle cells. Am J Hypertens: 2003; 16 708 714
48. Shirao S., Fujisawa H., Kudo A. et al. Inhibitory effects of eicosapentaenoic acid on chronic cerebral vasospasm after subarachnoid hemorrhage: possible involvement of a sphingosylphosphorylcholine-rho-kinase pathway. Cerebrovasc Dis: 2008; 26 30 37
49. Teuchner B., Orgul S., Ulmer H. et al. Reduced thirst in patients with a vasospastic syndrome. Acta Ophthalmol Scand: 2004; 82 738 740
50. Gherghel D., Orgul S., Gugleta K. et al. Retrobulbar blood flow in glaucoma patients with nocturnal over-dipping in systemic blood pressure. Am J Ophthalmol: 2001; 132 641 647
51. Wunderlich K., Zimmerman C., Gutmann H. et al. Vasospastic persons exhibit differential expression of ABC-transport proteins. Mol Vis: 2003; 9 756 761
52. Gasser P., Meienberg O. Finger microcirculation in classical migraine. A video-microscopic study of nailfold capillaries. Eur Neurol: 1991; 31 168 171
53. Palmer K. T., Griffin M. J., Syddall H. E. et al. Raynaud's phenomenon, vibration induced white finger, and difficulties in hearing. Occup Environ Med: 2002; 59 640 642
54. Krauchi K., Deboer T. The interrelationship between sleep regulation and thermoregulation. Front Biosci: 2010; 15 604 625
55. Pache M., Krauchi K., Cajochen C. et al. Cold feet and prolonged sleep-onset latency in vasospastic syndrome. Lancet: 2001; 358 125 126
56. Mozaffarieh M., Hauenstein D., Schoetzau A. et al. Smell perception in normal tension glaucoma patients. Mol Vis: 2010; 16 506 510
57. Pache M., Ochs J., Genth E. et al. Increased plasma endothelin-1 levels in fibromyalgia syndrome. Rheumatology (Oxford): 2003; 42 493 494